Northwire Canada EditionTuesday, July 21, 2026
Northwire
LOD 0.280 −5.1% FVL 0.960 +5.5% BAG 0.210 +23.5% FMN 0.240 +0.0% OMM 0.050 +0.0% VUL 0.405 +0.0% PNTR 0.320 +8.5% SWA 0.035 +0.0% GEN 0.065 +0.0% PAT 0.355 +0.0% TOM 0.115 +9.5% ALS 57.05 +0.2% LIO 0.130 −7.1% GEMC 0.020 +0.0% CBA 0.070 +7.7% PUMA 0.110 +0.0% LOD 0.280 −5.1% FVL 0.960 +5.5% BAG 0.210 +23.5% FMN 0.240 +0.0% OMM 0.050 +0.0% VUL 0.405 +0.0% PNTR 0.320 +8.5% SWA 0.035 +0.0% GEN 0.065 +0.0% PAT 0.355 +0.0% TOM 0.115 +9.5% ALS 57.05 +0.2% LIO 0.130 −7.1% GEMC 0.020 +0.0% CBA 0.070 +7.7% PUMA 0.110 +0.0%
Financings

Surenano Science closes $245,000 private placement

SURE · Price

Executive Summary

  • Surenano Science Ltd. has closed a private placement financing of 2.45 million common shares at $0.10 per share, raising total proceeds of $245,000.
  • The financing includes $85,000 in debt conversion from a related party, Charles Malette, who also contributed $110,000 in cash.
  • Upon completion of the debt settlement, Mr. Malette will hold 40% of the company's issued common shares.

Key Details

  • Total Shares Issued: 2,450,000 common shares.
  • Price Per Share: $0.10.
  • Total Gross Proceeds: $245,000.
  • Debt Conversion: $85,000 of the proceeds resulted from the conversion of debt owed to related party Charles Malette.
  • Cash Proceeds: $160,000 (Total $245,000 minus $85,000 debt conversion).
  • Use of Proceeds: Operating expenses (including legal and audit fees) and general working capital. No proceeds will be used for investor relations activities.
  • Hold Period: All securities issued are subject to a four-month-and-a-day hold period.
  • Related Party Transaction: Charles Malette (President, Secretary, and Director) participated by purchasing shares for $110,000 cash and converting $85,000 in debt.
  • Regulatory Exemption: The transaction is exempt from valuation and minority shareholder approval requirements under National Instrument 61-101 as it amounts to less than 25% of capitalization.
  • Post-Transaction Ownership: Mr. Malette will own 9,621,600 shares, representing 40% of the common shares issued upon completion of the debt settlement.
  • Other Participants: All other participants in the private placement are arm's-length parties.
Read the original news release →

More from Surenano Science Ltd